Skip to main content
. 2021 Jul 23;11:15125. doi: 10.1038/s41598-021-94584-9

Figure 6.

Figure 6

Possible molecular pathways affected by VEGFR2 and VEGF-A targeted therapy. The figures were generated by Microsoft Powerpoint (16.16.27) (https://www.microsoft.com/ja-jp/microsoft-365/powerpoint).